<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000752243"><TermName>OEPA regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination that is often used with radiation therapy to treat a certain type of childhood Hodgkin lymphoma in males. It includes the drugs vincristine sulfate (Oncovin), etoposide, prednisone, and doxorubicin hydrochloride (Adriamycin). Also called OEPA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000754484" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;OEPA regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000754483" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen OEPA&quot;" language="es" id="_4"/><SpanishTermName>régimen OEPA</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa a menudo con radioterapia para tratar cierto tipo de linfoma de Hodgkin infantil en varones. Se compone de los medicamentos de sulfato de vincristina (Oncovin), etopósido, prednisona y clorhidrato de doxorrubicina (Adriamycin). También se llama OEPA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2013-09-20</DateFirstPublished></GlossaryTerm>
